Project Details
Description
Effect and safety of liraglutide 3.0 mg on weight management in children with obesity aged 6 to < 12 years: 56-week, double-blind, randomised, placebo-controlled trial, Phase 3A
| Status | Active |
|---|---|
| Effective start/end date | 3/15/21 → 12/31/25 |
Funding
- NOVO NORDISK, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.